Breaking News Instant updates and real-time market news.

CYAD

Celyad

$31.00

-2.2 (-6.63%)

16:38
05/15/18
05/15
16:38
05/15/18
16:38

Celyad files to sell 1.8M ordinary shares

Which is comprised of an offer of ordinary shares in the form of American Depositary Shares in the United States, Canada and certain countries outside of Europe, and an offer of ordinary shares in Europe and certain countries outside of the United States and Canada in a concurrent private placement. Wells Fargo Securities and Bryan, Garnier & Co. are acting as joint bookrunning managers for the offering. Bank Degroof Petercam NV and LifeSci Capital are acting as co-managers for the offering. Kempen & Co NV is Celyad's advisor in connection with the offering.

CYAD Celyad
$31.00

-2.2 (-6.63%)

10/09/17
PIPR
10/09/17
NO CHANGE
Target $74
PIPR
Overweight
Celyad price target raised to $74 from $49 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff raised his price target for Celyad to $74 after the company last week reported the first ever Morphologic Leukemia-Free Status in an Acute Myeloid Leukemia patient in the first dose cohort of the Phase Ib Think study of CYAD-01 without preconditioning. Fourteen solid and hematologic tumor patients have been dosed in Think and escalation continues with no deaths, Tenthoff tells investors in an intraday research note. He added $258M in value for CYAD-01 in colorectal cancer based on the two patients with stable disease in Think and Celyad's plans to expand enrollment and initiate the Shrink and Link studies. The analyst, who points out his firm has been retained by Celyad as its financial advisor to explore strategic alternatives, reiterates an Overweight rating on the shares.
04/27/18
PIPR
04/27/18
NO CHANGE
Target $74
PIPR
Overweight
Celyad durability of response for CYAD-01 encouraging, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff said he was encouraged by the durability of response, without reports of cytokine release syndrome or neurotoxicity, for a relapsed/refractory Acute Myeloid Leukemia patient 9 months after receiving Celyad's CYAD-01 infusions. Following the publication of the case report, Tenthoff reiterates his Overweight rating and $74 price target on Celyad shares

TODAY'S FREE FLY STORIES

09:05
11/14/18
11/14
09:05
11/14/18
09:05
General news
U.S. equities are in rebound mode »

U.S. equities are in…

LUV

Southwest

$52.73

0.83 (1.60%)

09:04
11/14/18
11/14
09:04
11/14/18
09:04
Conference/Events
National Transportation Safety Board to hold an investigative hearing »

The National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$162.64

-1.185 (-0.72%)

09:03
11/14/18
11/14
09:03
11/14/18
09:03
Initiation
Allergan initiated  »

Leerink sees Allergan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

ABT

Abbott

$69.50

-1.06 (-1.50%)

09:02
11/14/18
11/14
09:02
11/14/18
09:02
Hot Stocks
Abbott recommends rejection of below-market mini-tender offer by Baker Mills »

Abbott received notice of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

APD

Air Products

$158.15

0.65 (0.41%)

09:02
11/14/18
11/14
09:02
11/14/18
09:02
Hot Stocks
Air Products, Sonatrach announce industrial gases agreements in Algeria »

Air Products and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

CTSH

Cognizant

$69.59

0.03 (0.04%)

09:00
11/14/18
11/14
09:00
11/14/18
09:00
Recommendations
Cognizant analyst commentary  »

Cognizant investor day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 26

    Nov

  • 02

    Dec

AMAT

Applied Materials

$33.48

0.87 (2.67%)

08:59
11/14/18
11/14
08:59
11/14/18
08:59
Recommendations
Applied Materials analyst commentary  »

Applied Materials price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

VERI

Veritone

$6.75

-0.14 (-2.03%)

08:58
11/14/18
11/14
08:58
11/14/18
08:58
Recommendations
Veritone analyst commentary  »

Veritone price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

SABR

Sabre

$25.17

0.27 (1.08%)

08:57
11/14/18
11/14
08:57
11/14/18
08:57
Conference/Events
Sabre to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

ECA

Encana

$8.10

-0.315 (-3.75%)

, AAPL

Apple

$192.23

-1.925 (-0.99%)

08:56
11/14/18
11/14
08:56
11/14/18
08:56
Options
Notable open interest changes for November 14th »

Tuesday's total…

ECA

Encana

$8.10

-0.315 (-3.75%)

AAPL

Apple

$192.23

-1.925 (-0.99%)

GE

General Electric

$8.61

0.625 (7.83%)

M

Macy's

$35.77

-1.27 (-3.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

PETQ

PetIQ

$31.27

-1.77 (-5.36%)

08:56
11/14/18
11/14
08:56
11/14/18
08:56
Recommendations
PetIQ analyst commentary  »

PetIQ price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BATRA

Liberty Braves Group

$25.06

0.15 (0.60%)

08:55
11/14/18
11/14
08:55
11/14/18
08:55
Conference/Events
Liberty Braves Group to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

FWONA

Formula One Group

$31.01

0.47 (1.54%)

08:55
11/14/18
11/14
08:55
11/14/18
08:55
Conference/Events
Formula One Group to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

BATRK

Liberty Braves

$24.88

0.02 (0.08%)

08:55
11/14/18
11/14
08:55
11/14/18
08:55
Conference/Events
Liberty Braves to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

08:54
11/14/18
11/14
08:54
11/14/18
08:54
Conference/Events
Federal Reserve Bank of Dallas president participates in a discussion »

Federal Reserve Bank of…

QRVO

Qorvo

$63.68

-0.12 (-0.19%)

, LITE

Lumentum

$38.95

1.445 (3.85%)

08:53
11/14/18
11/14
08:53
11/14/18
08:53
Recommendations
Qorvo, Lumentum, Apple analyst commentary  »

Qorvo price target…

QRVO

Qorvo

$63.68

-0.12 (-0.19%)

LITE

Lumentum

$38.95

1.445 (3.85%)

AAPL

Apple

$192.23

-1.925 (-0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

ON

ON Semiconductor

$17.35

0.54 (3.21%)

, ST

Sensata

$46.37

0.3 (0.65%)

08:52
11/14/18
11/14
08:52
11/14/18
08:52
Recommendations
ON Semiconductor, Sensata analyst commentary  »

Morgan Stanley says auto…

ON

ON Semiconductor

$17.35

0.54 (3.21%)

ST

Sensata

$46.37

0.3 (0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 08

    May

CELC

Celcuity

$27.94

-0.13 (-0.46%)

, PBYI

Puma Biotechnology

$22.03

-0.13 (-0.59%)

08:52
11/14/18
11/14
08:52
11/14/18
08:52
Recommendations
Celcuity, Puma Biotechnology analyst commentary  »

Celcuity price target…

CELC

Celcuity

$27.94

-0.13 (-0.46%)

PBYI

Puma Biotechnology

$22.03

-0.13 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

  • 03

    Dec

BHGE

Baker Hughes

$23.80

0.17 (0.72%)

, GE

General Electric

$8.61

0.625 (7.83%)

08:52
11/14/18
11/14
08:52
11/14/18
08:52
Syndicate
Baker Hughes 92M share secondary offering by GE prices at $23.00 »

Baker Hughes, a GE…

BHGE

Baker Hughes

$23.80

0.17 (0.72%)

GE

General Electric

$8.61

0.625 (7.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 14

    Nov

08:51
11/14/18
11/14
08:51
11/14/18
08:51
Conference/Events
House Financial Services Committee to hold a hearing »

The Committee holds a…

BHGE

Baker Hughes

$23.80

0.17 (0.72%)

08:51
11/14/18
11/14
08:51
11/14/18
08:51
Syndicate
Baker Hughes 92M share Secondary priced at $23.00 »

Morgan Stanley and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 14

    Nov

PCG

PG&E

$32.70

-0.25 (-0.76%)

08:50
11/14/18
11/14
08:50
11/14/18
08:50
Recommendations
PG&E analyst commentary  »

PG&E price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$64.78

0.55 (0.86%)

08:50
11/14/18
11/14
08:50
11/14/18
08:50
Conference/Events
Economic Club of New York to hold a luncheon meeting »

Luncheon Meeting with CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 14

    Jan

  • 15

    Apr

  • 13

    Jul

08:50
11/14/18
11/14
08:50
11/14/18
08:50
General news
Treasury Action: yields probed higher »

Treasury Action: yields…

08:49
11/14/18
11/14
08:49
11/14/18
08:49
Conference/Events
Federal Reserve Vice Chairman speaks before House Financial Services Committee »

Federal Reserve Vice…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.